| ?? |
?? ?? |
CAS |
MF |
 |
PHA-848125 |
802539-81-7 |
C25H32N8O |
 |
PURVALANOL A |
212844-53-6 |
C19H25ClN6O |
 |
Abemaciclib mesylate (LY2835219) |
1231930-82-7 |
C28H36F2N8O3S |
 |
PD0332991??????? |
827022-33-3 |
C26H35N7O6S |
 |
PHA767491???? |
845714-00-3 |
C12H11N3O |
![4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide](/CAS2/GIF/844442-38-2.gif) |
4-[(2,6-dichlorobenzoyl)amino]-N-4-piperidinyl1H-pyrazole-3-carboxamide |
844442-38-2 |
C16H17Cl2N5O2 |
 |
BMS-265246 |
582315-72-8 |
C18H17F2N3O2 |
 |
TG003 |
300801-52-9 |
C13H15NO2S |
 |
Ribociclib |
1211441-98-3 |
C23H30N8O |
 |
AS 604850 |
648449-76-7 |
C11H5F2NO4S |
![5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione](/CAS/GIF/958852-01-2.gif) |
5-[[4-(4-Pyridinyl)-6-quinolinyl]methylene]-2,4-thiazolidenedione |
958852-01-2 |
C18H11N3O2S |
 |
NVP-BGT226 |
1245537-68-1 |
C28H25F3N6O2.C4H4O4 |
![2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid](/CAS2/GIF/1173900-33-8.gif) |
2-[[(1R)-1-[7-methyl-2-(4-morpholinyl)-4-oxo-4h-pyrido[1,2-a]pyrimidin-9-yl]ethyl]amino]benzoic acid |
1173900-33-8 |
C22H24N4O4 |
 |
PIK-75 Hydrochloride |
372196-77-5 |
C16H15BrClN5O4S |
 |
VS-5584 |
1246560-33-7 |
C17H22N8O |
 |
CH5132799 |
1007207-67-1 |
C15H19N7O3S |
 |
PKI-402 |
1173204-81-3 |
C29H34N10O3 |
 |
CZC24832 |
1159824-67-5 |
C15H17FN6O2S |
 |
AVL-292 |
1202757-89-8 |
C22H22FN5O3 |
 |
PIK-294 |
900185-02-6 |
C28H23N7O2 |
 |
????(E7050) |
928037-13-2 |
C33H37F2N7O4 |
 |
LY 2874455 |
1254473-64-7 |
C21H19Cl2N5O2 |
 |
2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-1H-IMIDAZOLE |
189224-48-4 |
C13H14N2O |
 |
WZ8040 |
1214265-57-2 |
C24H25ClN6OS |
 |
Insulin-like Growth Factor-1 Receptor Inhibitor |
468740-43-4 |
C25H26ClN5O3 |
![5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine](/CAS/GIF/475488-23-4.gif) |
5-(3-Benzyloxyphenyl)-7-[trans-3-[(pyrrolidin-1-yl)methyl]cyclobutyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
475488-23-4 |
C28H31N5O |
 |
OSI-420 |
183320-51-6 |
C21H22ClN3O4 |
 |
ALK/IGF1R inhibitor |
1356962-20-3 |
C24H25ClN6O |
 |
ZM 306416 |
690206-97-4 |
C16H13ClFN3O2 |
![3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon](/CAS/GIF/194413-58-6.gif) |
3-[(2,4-Dimethylpyrrol-5-yl)methylidenyl]-2-indolinon |
194413-58-6 |
C15H14N2O |
 |
A66 |
1166227-08-2 |
C17H23N5O2S2 |
 |
AMG-208 |
1002304-34-8 |
C22H17N5O2 |
 |
KRN 633 |
286370-15-8 |
C20H21ClN4O4 |
 |
R428 |
1037624-75-1 |
C30H34N8 |
 |
CP-724714 |
537705-08-1 |
C27H27N5O3 |
 |
OSI-930 |
728033-96-3 |
C22H16F3N3O2S |
 |
BAY 80-6946 (Copanlisib) |
1032568-63-0 |
C23H28N8O4 |
 |
NVP-BVU 972 |
1185763-69-2 |
C20H16N6 |
 |
REVERSINE |
656820-32-5 |
C21H27N7O |
 |
PD153035 HCl |
183322-45-4 |
C16H14BrN3O2.HCl |
 |
AMG 458 |
913376-83-7 |
C30H29N5O5 |
 |
ARRY-380 |
937265-83-3 |
C29H27N7O4S |
 |
GNF 5837 |
1033769-28-6 |
C28H21F4N5O2 |
 |
IGF-1R Inhibitor II, N-(5-Chloro-2-methoxyphenyl)-Nμ-(2-methylquinolin-4-yl)urea |
196868-63-0 |
C18H16ClN3O2 |
![5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine](/CAS2/GIF/870483-87-7.gif) |
5-[3-Methoxy-4-(4-methoxy-benzyloxy)-benzyl]-pyrimidine-2,4-diamine |
870483-87-7 |
C20H22N4O3 |
 |
NVP-BHG712 |
940310-85-0 |
C26H20F3N7O |
 |
Tepotinib |
1100598-32-0 |
C29H28N6O2 |
 |
GSK1838705A |
1116235-97-2 |
C27H29FN8O3 |
 |
TAK-285 |
871026-44-7 |
C26H25ClF3N5O3 |
 |
XL765 |
1349796-36-6 |
C31H29N5O6S |
![3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione](/CAS/GIF/905854-02-6.gif) |
3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione |
905854-02-6 |
C23H19N3O2 |
 |
3,3'-(2,4-Diamino-6,7-pteridinediyl)bisphenol |
677297-51-7 |
C18H14N6O2 |
 |
Icotinib |
610798-31-7 |
C22H21N3O4 |
 |
Capmatinib |
1029712-80-8 |
C23H17FN6O |
 |
BMS-754807 |
1001350-96-4 |
C23H24FN9O |
 |
Tie2?????? |
948557-43-5 |
C26H21N3O2S |
 |
BMS-794833 |
1174046-72-0 |
C23H15ClF2N4O3 |
 |
PI-3065 |
955977-50-1 |
C27H31FN6OS |
 |
Lorlatinib |
1454846-35-5 |
C21H19FN6O2 |
 |
LRRK2-IN-1 |
1234480-84-2 |
C31H38N8O3 |
 |
ARRY-334543 |
845272-21-1 |
C22H19ClN6O2S |
 |
SU 9516 |
377090-84-1 |
C13H11N3O2 |
 |
Mk-2461 . |
917879-39-1 |
C24H25N5O5S |
 |
SR 1078 |
1246525-60-9 |
C17H10F9NO2 |
 |
AST-1306 |
1050500-29-2 |
C31H26ClFN4O5S |
 |
Poziotinib (HM781-36B) |
1092364-38-9 |
C23H21Cl2FN4O3 |
 |
Mycophenolate mofetil |
115007-34-6 |
C23H31NO7 |
 |
AVP-AEW541 |
475489-16-8 |
C27H29N5O |
 |
XL-388 |
1251156-08-7 |
C23H22FN3O4S |
 |
P276 |
920113-03-7 |
C21H21Cl2NO5 |
 |
NU 6027 |
220036-08-8 |
C11H17N5O2 |
 |
????????? |
857890-39-2 |
C22H23ClN4O7S |
 |
?????? |
109581-93-3 |
C44H71NO13 |
 |
WAY-600 |
1062159-35-6 |
C28H30N8O |
 |
ML167 |
1285702-20-6 |
C19H17N3O3 |
 |
HS-173 |
1276110-06-5 |
C21H18N4O4S |
 |
UNC2881 |
1493764-08-1 |
C25H33N7O2 |
 |
TYRPHOSTIN AG 1024 |
65678-07-1 |
C14H13BrN2O |
 |
4,4'-propylenebis(piperazine-2,6-dione) |
21416-67-1 |
C11H16N4O4 |
 |
NVP-BSK805 |
1092499-93-8 |
C27H28F2N6O |
![3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide](/CAS/GIF/1001917-37-8.gif) |
3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide |
1001917-37-8 |
C25H21N5O3S |
![N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine](/CAS/GIF/1097917-15-1.gif) |
N2-[2-Methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-1,3,5-triazine-2,4-diamine |
1097917-15-1 |
C29H40N8O3S |
 |
E-3810 |
1058137-23-7 |
C26H25N3O4 |
 |
DCC-2618 |
1225278-16-9 |
C26H21F2N5O3 |
 |
ANA12 |
219766-25-3 |
C22H21N3O3S |
![1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine](/CAS2/GIF/343787-29-1.gif) |
1-{2-[5-(2-Methoxy-ethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine |
343787-29-1 |
C24H27N5O2 |
 |
CAY10505 |
1218777-13-9 |
C14H8FNO3S |
 |
WZ3146 |
1214265-56-1 |
C24H25ClN6O2 |
 |
PIK-293 |
900185-01-5 |
C22H19N7O |
 |
TG 100713 |
925705-73-3 |
C12H10N6O |
 |
UNC2250 |
1493694-70-4 |
C24H36N6O2 |
 |
PD168393 |
194423-15-9 |
C17H13BrN4O |
 |
???????? |
50-18-0 |
C7H15Cl2N2O2P |
 |
Ro 3306 |
872573-93-8 |
C18H13N3OS2 |
![2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]-](/CAS/GIF/194423-06-8.gif) |
2-ButynaMide, N-[4-[(3-broMophenyl)aMino]-6-quinazolinyl]- |
194423-06-8 |
C18H13BrN4O |
 |
XL413 (BMS-863233) |
1169562-71-3 |
C14H13Cl2N3O2 |
 |
SAR 131675 |
1433953-83-3 |
C18H22N4O4 |
 |
ZM 323881 hydrochloride |
193000-39-4 |
C22H19ClFN3O2 |
 |
CNX-2006 |
1375465-09-0 |
C26H27F4N7O2 |
 |
SKLB1002 |
1225451-84-2 |
C13H12N4O2S2 |